Hepatitis B
HBV (hepadnavirus; RC-DNA; 3.2 kb) infects 296M people; replicates via pgRNA/reverse transcriptase; tenofovir/entecavir suppress but do not clear cccDNA; HBeAg seroconversion marks immune control; 50-55% of global HCC; functional cure (HBsAg loss) is emerging treatment goal.
Entry Metadata
| Field | Value |
|---|---|
| ID | hepatitis-b |
| Name | Hepatitis B |
| Status | draft |
| Last reviewed | 2026-06-08 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599. · PubMed 29405329
- Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-1555. · PubMed 26231459